ATE107656T1 - Verfahren zur herstellung von 14-alpha-hydroxy-4- androsten-3,6,17, trion. - Google Patents

Verfahren zur herstellung von 14-alpha-hydroxy-4- androsten-3,6,17, trion.

Info

Publication number
ATE107656T1
ATE107656T1 AT90102302T AT90102302T ATE107656T1 AT E107656 T1 ATE107656 T1 AT E107656T1 AT 90102302 T AT90102302 T AT 90102302T AT 90102302 T AT90102302 T AT 90102302T AT E107656 T1 ATE107656 T1 AT E107656T1
Authority
AT
Austria
Prior art keywords
alpha
hydroxy
preparation
androsene
trion
Prior art date
Application number
AT90102302T
Other languages
English (en)
Inventor
Masamichi Nakakoshi
Kohji Tamura
Makoto Yoshihama
Nobuo Miyata
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of ATE107656T1 publication Critical patent/ATE107656T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90102302T 1989-02-07 1990-02-06 Verfahren zur herstellung von 14-alpha-hydroxy-4- androsten-3,6,17, trion. ATE107656T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1027824A JPH0643439B2 (ja) 1989-02-07 1989-02-07 光による6β,14α‐ジヒドロキシ‐4‐アンドロステン‐3,17‐ジオンの6β位水酸基の酸化方法

Publications (1)

Publication Number Publication Date
ATE107656T1 true ATE107656T1 (de) 1994-07-15

Family

ID=12231698

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90102302T ATE107656T1 (de) 1989-02-07 1990-02-06 Verfahren zur herstellung von 14-alpha-hydroxy-4- androsten-3,6,17, trion.

Country Status (5)

Country Link
US (1) US5098535A (de)
EP (1) EP0382162B1 (de)
JP (1) JPH0643439B2 (de)
AT (1) ATE107656T1 (de)
DE (1) DE69010025T2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06225793A (ja) * 1992-11-27 1994-08-16 Nippon Kayaku Co Ltd 6β,14α−ジヒドロキシ−4−アンドロステン−3,17−ジオンの新規製造法
EP0626388A3 (en) * 1993-05-28 1996-06-19 Nippon Kayaku Kk 14alpha-hydroxy-4-androstene-3,6,17-trione hydrate crystal and process for producing same.
ES2817789T3 (es) 2012-11-12 2021-04-08 Hollister Inc Conjunto de catéter intermitente
EP2919825B1 (de) 2012-11-14 2018-10-17 Hollister Incorporated Einmalkatheter mit selektiv abbaubarem innenkern
DK3862031T3 (da) 2013-11-08 2023-09-25 Hollister Inc Smurte, oleofile katetre
HUE049637T2 (hu) 2013-12-12 2020-09-28 Hollister Inc Toalettben lehúzható katéterek
AU2014363933B2 (en) 2013-12-12 2019-10-10 Hollister Incorporated Flushable disintegration catheter
LT3079749T (lt) 2013-12-12 2019-12-27 Hollister Incorporated Srove nuplaunami kateteriai
LT3079750T (lt) 2013-12-12 2020-07-27 Hollister Incorporated Srove nuplaunami kateteriai
LT3310404T (lt) 2015-06-17 2024-04-10 Hollister Incorporated Selektyviai vandenyje tirpstančios medžiagos ir iš tokių medžiagų kateteriai

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2900382A (en) * 1952-06-28 1959-08-18 Syntex Sa Method of making delta4,6 steroid compounds from delta4 steroid compounds
ATE78825T1 (de) * 1987-02-06 1992-08-15 Snow Brand Milk Products Co Ltd Neue androst-4-en-3,17-dion-derivate und verfahren zur herstellung.
JPS63192794A (ja) * 1987-02-06 1988-08-10 Snow Brand Milk Prod Co Ltd 14α−ヒドロキシ−4−アンドロステン−3,6,17−トリオン

Also Published As

Publication number Publication date
EP0382162A2 (de) 1990-08-16
EP0382162A3 (de) 1991-03-13
EP0382162B1 (de) 1994-06-22
JPH02207095A (ja) 1990-08-16
DE69010025D1 (de) 1994-07-28
DE69010025T2 (de) 1994-12-15
US5098535A (en) 1992-03-24
JPH0643439B2 (ja) 1994-06-08

Similar Documents

Publication Publication Date Title
DE68919530D1 (de) Verfahren und Zwischenprodukte für die Herstellung von Bis(aminoalkyl)polydiorganosiloxanen.
DE3750749D1 (de) Modifiziertes Dienpolymer und Verfahren zu seiner Herstellung.
DE68919939D1 (de) Verfahren zur Herstellung von Alkenylbernsteinsäureanhydrid-Derivaten.
ATE112963T1 (de) Gewebeentzusammensetzung und verfahren.
DE68910145D1 (de) Verfahren zur Herstellung von Azolylmethyl-cyclopentanol-Derivaten.
DE68927703D1 (de) Verfahren zur Herstellung von 2,3-Dimethylbutenen
DE68920234D1 (de) Verfahren zur Herstellung eines oxidischen Supraleiters.
DE68927949D1 (de) 3,9-Diphosphaspiroundecane und Verfahren zur Herstellung von 3,9-Diphosphaspiroundecanen
DE69010025D1 (de) Verfahren zur Herstellung von 14-Alpha-hydroxy-4-androsten-3,6,17, trion.
DE3777618D1 (de) Elektroabscheidungsverfahren und waesserige harz-lackzusammensetzung.
DE68912160D1 (de) Verfahren zur Herstellung von beta-Lactamderivaten.
DE69007323D1 (de) Verfahren zur Herstellung von sec.-Butylbenzol.
DE68902334D1 (de) Verfahren zur herstellung von automobil-karosserieteilen, insbesondere heckspoiler und nach diesem verfahren hergestellte gegenstaende.
DE69009682D1 (de) Verfahren zur Herstellung von Cyclohexanolderivaten.
DE68916396D1 (de) Verfahren zur Herstellung eines Carbonsäurealkenylesters.
DE3887212D1 (de) Verfahren zur Herstellung von Derivaten von 6,7-Diazyl-7-desacetylforskolin.
DE59309002D1 (de) Verfahren zur Herstellung von 6-Chlor-(6H)-dibenz-(c,e)(1,2)-oxaphosphorin
DE69014576D1 (de) Verfahren zur Herstellung von 3-Dibutylamino-6-methyl-7-anilinofluoran.
DE59106420D1 (de) Verfahren zur Herstellung von Phosphatidylcholinderivaten.
DE69019843D1 (de) Verfahren zur Herstellung von NADH-Oxydase.
DE69013726D1 (de) Verbessertes Verfahren für die Herstellung von o-Carboxypyridyl- und o-Carboxychinolylimidazolinonen.
DE3785537D1 (de) Mikroorganismus und verfahren zur herstellung von oxydationsverbindungen mit diesem mikroorganismus.
DE68913779D1 (de) D-Amidase und Verfahren zur Herstellung von D-alpha-Alanin und/oder L-alpha-Alaninamid.
DE59006265D1 (de) Verfahren zur Herstellung von 2-Amino-4-fluorpyrimidinderivaten.
DE69021442D1 (de) Verfahren zur Herstellung von 2, 3-Di-substituierten Cyclopentanonen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee